2025-11-26 | Company
Sever Pharma Solutions Appoints Linda Rebert as VP Operations
We are pleased to announce the appointment of Linda Rebert as its new VP Operations, effective December 1, 2025.
2025-11-26 | Company
We are pleased to announce the appointment of Linda Rebert as its new VP Operations, effective December 1, 2025.
2025-11-12 | Company
We are proud to celebrate our 50th anniversary this year. The milestone marks five decades of innovation, expertise, and partnership in pharmaceutical development and manufacturing.
2025-09-01 | Company
We are pleased to announce the appointment of Malin Wendt as the new Supply Chain Management Director, effective September 1st, 2025.
2025-08-19 | Company
Sever Pharma Solutions is pleased to announce the publication of its Sustainability Report 2024, highlighting our ongoing commitment to responsible business practices and sustainable growth.
2025-08-14 | Company
Sever Pharma Solutions has made an expanded agreement with Silo Pharma, Inc. (Nasdaq: SILO).
2025-07-02 | Company
We are pleased to announce the appointment of Fredrik Hultenius as new Chief Executive Officer, effective July 1st, 2025.
2025-06-30 | Company
We’re delighted to share insights from Tony Listro, VP and Site Head of Sever Pharma Solution following a great interview at BIO2025.
2025-06-17 | Company
Capable to handle high-potent and cytotoxic injectable drugs at its Malmö facility.
2025-04-23 | Company
In 2024, our Putnam site fully commissioned and qualified two new High Potent API processing suites.
2025-04-07 | Company
Sever Pharma Solutions is pleased to announce Ulrike Foley as the new Head of Global Business Development and Marketing.